Comparative evaluation of the isotopes 86Rb and 51Cr in a humoral cytotoxicity system

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

International journal of cancer·2015

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.

Oncology·2012

Prognostic value of initial tumor parameters after metastatic relapse.

Cancer investigation·2011

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Breast (Edinburgh, Scotland)·2011

Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2011